BIOTECH & MAKE IN INDIA
SUMMARY
- India is among the top 12 biotech destinations in the world and ranks third in the Asia Pacific
- Second highestnumber of USFDA approved plants
- USD 3.7 Billion to be spent on biotechnology from 2012-17
- No.1 producer of Hepatitis B vaccine recombinant
- USD 100 Billion industry by 2025
- Large consumer base with increasing disposable income
STATISTICS
- The Indian biotech industry is expected to grow at 30.46 percent CAGR to US$ 100 billion by 2025
- The Biotechnology Industry in India has grown from $1.1 Billion in 2005 ti $7 Billion in 2015 and is expected to reach $11.6 Billion in 2017
- The gowth is due to a range of positive trends such as growing demand for healthcare services, increase demand for food & nutrition intensive R&D activities and strong govermenet initiatives
- The Indian biotech sector is divided into five major segments- bio-pharma, bio-services, bio-agri, bio-industrial and bio-informatics
- The bio-pharmaceutical sector accounts for the largest share of the biotech industry with a share of 62% of total revenues in 2015, followed by bio-services (18%), bio-agri (15%), bio-industrial (4%) and bio-informatics (1%)
- Supported 104 new startups, 346 companies, 509 projects including 115 collaborative projects through B I R A C, a Public Sector Unit of Goverment of India
- 100 Intellectual Property facilitated
- 175,000 sq. ft. of bioincubation space created and the target to support 50 world class bioincubators by 2020
- 5 University Innovation Clusters created
- 1 Regional Innovation Centre
- 3 Industrail Facilities
- 2 Contract Service Facilities
INVESTMENT OPPORTUNITIES
- The Department of Biotechnology has established biotech parks in various parts of the country to facilitate product development, research and innovation, and the development of biotechnology industrial clusters
- Operational biotech parks are located at Lucknow in Uttar Pradesh, Bangalore in Karnataka, Kalamassery and Kochi in Kerela, Guwahati in Assam and Chindwara in Madhya Pradesh
- Biotech Industrial cluters are located in Bangalore (Bangalore Lifesciences cluster and Bangalore Bioinnovation Centre), NCR Faridabad, Pune, Hyderabad and Chennai (Medtech)
- The parks offer investors incubator facilities, pilot plants facilities for solvent extraction and laboratory and office spaces
- BIRAC has funded 15 incubation centers offering a whole host of instrumentation facilities and services
- India constitutes around 8% of the total global generics market, by volume indicating a huge untapped opportunity in the sector
- Hybrid seeds, including GM seeds, represents new business opportunities in India based on yield improvement
- New Investment opportunities in India are in the areas of
- Drug discovery and clinical trails
- Medical devices manufacturing
- Biosimilars
- Secondary agriculture
- BIRAC has launched an Equity based fund - AcE Fund. An equity fund to address to accelerate the growth of entrepreneurs in the field of biotechnology by lending a funding support of up to - USD 150,000 for promising ventures
Posts
